Healthcare -
Biotechnology - NASDAQ - US
$ 6.02
-3.06 %
$ 1.83 B
Market Cap
-4.07
P/E
IOVA - CASH & EQUIVALENTS
Cash & Equivalents IOVA - Iovance Biotherapeutics, Inc.
115 M
LAST VALUE
21.19%
2 YEAR CAGR
6.94%
5 YEAR CAGR
19.30%
10 YEAR CAGR